178 related articles for article (PubMed ID: 848974)
1. Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results.
Vonderheid EC; Van Scott EJ; Johnson WC; Grekin DA; Asbell SO
Arch Dermatol; 1977 Apr; 113(4):454-62. PubMed ID: 848974
[TBL] [Abstract][Full Text] [Related]
2. A 10-year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated by total-skin electron-beam radiation therapy.
Vonderheid EC; Van Scott EJ; Wallner PE; Johnson WC
Cancer Treat Rep; 1979 Apr; 63(4):681-9. PubMed ID: 109206
[TBL] [Abstract][Full Text] [Related]
3. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
Ramsay DL; Parnes RE; Dubin N
Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
[TBL] [Abstract][Full Text] [Related]
4. Prolonged remission of tumor-stage mycosis fungoides by topical immunotherpay.
Vonderheid EC; Dellatorre DL; Van Scott EJ
Arch Dermatol; 1981 Sep; 117(9):586-9. PubMed ID: 6457569
[TBL] [Abstract][Full Text] [Related]
5. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
[TBL] [Abstract][Full Text] [Related]
6. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.
Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT
Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308
[TBL] [Abstract][Full Text] [Related]
7. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.
Constantine VS; Fuks ZY; Farber EM
Arch Dermatol; 1975 Apr; 111(4):484-8. PubMed ID: 1122150
[TBL] [Abstract][Full Text] [Related]
8. Failure to induce tolerance to mechlorethamine hydrochloride.
Leshaw S; Simon RS; Bear RL
Arch Dermatol; 1977 Oct; 113(10):1406-8. PubMed ID: 911169
[TBL] [Abstract][Full Text] [Related]
9. Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group.
Molin L; Thomsen K; Volden G
Acta Derm Venereol; 1979; 59(1):64-8. PubMed ID: 84470
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of delayed hypersensitivity to dinitrochlorobenzene and mechlorethamine hydrochloride in cutaneous T cell lymphoma.
Vonderheid EC; Ekbote SK; Kerrigan K; Kalmanson JD; Van Scott EJ; Rook AH; Abrams JT
J Invest Dermatol; 1998 Jun; 110(6):946-50. PubMed ID: 9620303
[TBL] [Abstract][Full Text] [Related]
11. [Modern therapy of mycosis fungoides].
Roenigk HH
Hautarzt; 1983 Jun; 34(6):266-72. PubMed ID: 6874333
[TBL] [Abstract][Full Text] [Related]
12. Topical mechlorethamine therapy for mycosis fungoides. Proposed schedule to overcome drug resistance.
Volden G; Molin L; Thomsen K
Arch Dermatol; 1982 Feb; 118(2):138-9. PubMed ID: 7059219
[No Abstract] [Full Text] [Related]
13. The treatment of mycosis fungoides: adjuvant topical mechlorethamine after electron beam therapy.
Price NM; Hoppe RT; Constantine VS; Fuks ZY; Farber EM
Cancer; 1977 Dec; 40(6):2851-3. PubMed ID: 412580
[TBL] [Abstract][Full Text] [Related]
14. [Mycosis fungoides].
Richard-Lallemand MA; Carsuzaa F
Ann Dermatol Venereol; 1997; 124(1):69-90. PubMed ID: 9686047
[No Abstract] [Full Text] [Related]
15. Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group.
Lamberg SI; Green SB; Byar DP; Block JB; Clendenning WE; Epstein EH; Fuks ZY; Golitz LE; Lorincz AL; Michel B; Roenigk HH; Van Scott EJ; Vonderheid EC; Thomas RJ
Cancer Treat Rep; 1979 Apr; 63(4):701-7. PubMed ID: 376140
[TBL] [Abstract][Full Text] [Related]
16. Treatment of mycosis fungoides with topical nitrosourea compounds: Further studies.
Zackheim HS; Epstein EH
Arch Dermatol; 1975 Dec; 111(12):1564-70. PubMed ID: 1200661
[TBL] [Abstract][Full Text] [Related]
17. Treatment of mycosis fungoides: total-skin electron-beam irradiation vs topical mechlorethamine therapy.
Hamminga B; Noordijk EM; van Vloten WA
Arch Dermatol; 1982 Mar; 118(3):150-3. PubMed ID: 7065660
[TBL] [Abstract][Full Text] [Related]
18. Topical nitrogen mustard in mycosis fungoides.
Zachariae H
Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954
[TBL] [Abstract][Full Text] [Related]
19. Nonspecific antigen reactions.
Klein E; Rosner D; Holtermann OA; Stoll HL; Song SY
Natl Cancer Inst Monogr; 1976 Nov; 44():87-97. PubMed ID: 799764
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides.
Kim YH; Chow S; Varghese A; Hoppe RT
Arch Dermatol; 1999 Jan; 135(1):26-32. PubMed ID: 9923777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]